Carbon Impact Report Shows Growing Lab Commitment to Reducing Carbon Emissions
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
Already a member? Log in here
Author Information
Scott Wallask
Scott Wallask is senior editorial manager at G2 Intelligence and its sibling brands, The Dark Report and Today’s Clinical Lab. During his 30-year career, he has covered the clinical lab, healthcare, and high-tech markets during stints at TechTarget, HCPro, ZoomInfo, and the SAPinsider family of online publications. A former newspaper reporter, he graduated from Northeastern University with a bachelor’s degree in journalism. He can be reached at swallask@clinicallab.com.
Posts by the Author
Compliance-lcaDOJ-lcaDOJ-nirEnforcement-lcaEnforcement-lirEnforcement-nirEssentialFalse Claims-lcaLab Industry AdvisorScott Wallask
Lessons in Laboratory Compliance from a $30 Million Settlement
‘Lean lab’ setup appears to have caught the eyes of investigators
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Already a member? Log in here
CLIA-lcaCLIA-nirCMS-lcaCMS-lirCMS-nirEssentialFDA-lcaFDA-lirFDA-nirLab Industry AdvisorLegislation-lcaLegislation-lirLegislation-nirScott Wallask
New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
CLIA-lcaCLIA-nirCMS-lcaCMS-lirCMS-nirCompliance-lcaCompliance-nirEssentialLab Industry AdvisorScott Wallask
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
CLIA-lcaCLIA-nirCMS-lcaCMS-lirCMS-nirEnforcement-lcaEnforcement-lirEnforcement-nirEssentialHealth care reform-lirLab Industry AdvisorLegislation-lcaLegislation-lirLegislation-nirPAMA-lirReimbursement-lcaReimbursement-lirReimbursement-nirScott Wallask
Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
Coding-lcaCompliance-lcaCompliance-nirEssentialLab Industry AdvisorOIG-nirReimbursement-lcaReimbursement-lirReimbursement-nirScott Wallask
OIG Report on Lab Testing Should Prompt Compliance Review
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending
Already a member? Log in here
CMS-lcaCMS-lirCMS-nirEssentialFee Schedules-lirFee Schedules-nirLab Industry AdvisorReimbursement-lcaReimbursement-lirReimbursement-nirScott Wallask
Up Next for Labs: PAMA Reporting Window Opens May 1
Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027
Already a member? Log in here
EssentialFee Schedules-lirFee Schedules-nirLab Industry AdvisorLegislation-lcaLegislation-lirLegislation-nirPAMA-lirReimbursement-lcaReimbursement-lirReimbursement-nirScott Wallask
PAMA Delay Proposed Until 2027 Under a New Federal Spending Bill
However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly
Already a member? Log in here
